Diseases of the Abdomen and Pelvis 2018-2021 : : Diagnostic Imaging - IDKD Book.

Diseases of the Abdomen and Pelvis 2018-2021 : : Diagnostic Imaging - IDKD Book.

Saved in:
Bibliographic Details
Superior document:IDKD Springer Series
:
Hodler, Juerg.
TeilnehmendeR:
Kubik-Huch, Rahel A.
von Schulthess, , Gustav K.
Place / Publishing House:Cham : : Springer International Publishing AG,, 2018.
©2018.
Year of Publication:2018
Edition:1st ed.
Language:English
Series:IDKD Springer Series
Online Access:
Physical Description:1 online resource (262 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Intro
  • Contents
  • 1: Renal Tumors
  • 1.1 Introduction
  • 1.2 Modalities for Imaging Renal Masses
  • 1.2.1 Ultrasound
  • 1.2.2 CT and MRI
  • 1.3 Very Small Renal Masses (&lt
  • 1-1.5 cm)
  • 1.4 Cystic Renal Masses
  • 1.5 Angiomyolipomas (AMLs)
  • 1.6 Other Solid Renal Masses
  • 1.6.1 Oncocytomas
  • 1.6.2 Renal Cancers
  • 1.6.2.1 Clear Cell Renal Cancer
  • 1.6.2.2 Papillary Renal Cancer
  • 1.6.2.3 Chromophobe Renal Cancer
  • 1.6.2.4 Uncommon Renal Cancer Cell Types
  • 1.6.3 Urothelial Neoplasms, Lymphoma, and Renal Artery Aneurysms
  • 1.7 Solid Renal Mass Growth Rates
  • 1.8 Radiomics
  • 1.9 Use of Imaging for Solid Renal Mass Differentiation
  • 1.10 Percutaneous Biopsy of Renal Masses
  • 1.11 Pretreatment Assessment of Renal Cancer
  • 1.11.1 Staging
  • 1.11.2 RENAL Nephrometry
  • 1.12 Renal Cancer Management
  • 1.13 Imaging After Renal Cancer Treatment
  • 1.13.1 After Renal Mass Ablation or Resection
  • 1.13.2 Imaging After Partial or Total Nephrectomy
  • 1.13.3 Imaging After Treatment of Metastatic Disease
  • 1.13.3.1 RECIST
  • 1.13.3.2 Multikinase Inhibitors
  • 1.13.3.3 Immunotherapy
  • 1.13.3.4 Complications of Multikinase Inhibitor Treatment and Immunotherapy
  • 1.14 Concluding Remarks
  • References
  • 2: MRI of the Pelvic Floor and MR Defecography
  • 2.1 Introduction
  • 2.2 Functional Anatomy of the Pelvic Floor
  • 2.2.1 Pathogenesis
  • 2.2.2 Levator Ani Muscle (LAM)
  • 2.2.3 Endopelvic Fascia
  • 2.2.3.1 Pubocervical Fascia
  • 2.2.3.2 Rectovaginal Fascia
  • 2.2.4 Etiology of Pelvic Floor Failure
  • 2.2.5 Indication for Dynamic Pelvic Floor Imaging
  • 2.3 Diagnosis of PFD Using Dynamic MRI
  • 2.3.1 General Preparation
  • 2.3.2 DPF-MRI Procedure
  • 2.3.2.1 Patients' Positioning and Preparation
  • 2.3.2.2 MRI Sequences
  • 2.3.3 MRI Interpretation
  • 2.3.3.1 Measurement and Grading.
  • 2.3.3.2 Further Evaluation
  • 2.4 Overview on Compartment-Based Symptoms
  • 2.4.1 Anterior Compartment
  • 2.4.2 Middle Compartment
  • 2.4.3 Posterior Compartment
  • 2.5 Concluding Remarks
  • References
  • 3: Benign Disease of the Uterus
  • 3.1 Introduction
  • 3.2 Normal Anatomy of the Uterus
  • 3.3 MRI Technique
  • 3.4 Congenital Anomalies
  • 3.4.1 Class 0 (Normal Uterus)
  • 3.4.2 Class U1 (Dysmorphic Uterus)
  • 3.4.3 Class U2 (Septate Uterus) (Fig. 3.4)
  • 3.4.4 Class U3 (Bicorporeal Uterus, syn: Bicornuate Uterus) (Fig. 3.5)
  • 3.4.5 Class U4 (Hemi-uterus) (Fig. 3.6)
  • 3.4.6 Class U5 (Aplastic Uterus)
  • 3.4.7 Class U6 (Unclassified Cases)
  • 3.4.8 Classification of Congenital Anomalies of the Cervix and the Vagina
  • 3.5 Leiomyoma (Figs. 3.7 and 3.8)
  • 3.6 Adenomyosis (Fig. 3.9)
  • 3.7 Myometrial Contractions
  • 3.8 Endometrial Pathology
  • 3.9 Benign Pathology of the Cervix and Vagina
  • 3.10 Deep Endometriosis
  • 3.11 Concluding Remarks
  • References
  • 4: Therapy Monitoring of Oncologic Disease in the Abdomen (Including PET/CT)
  • 4.1 Introduction
  • 4.2 Assessment of Local Response to Neoadjuvant Treatment in Rectal Cancer
  • 4.2.1 Selection of Patients for Neoadjuvant Therapy
  • 4.2.2 Assessment of Local Tumor Response and Resectability
  • 4.2.3 Assessment of Complete Response After Chemoradiotherapy
  • 4.2.4 Assessment of Response for Nodal Disease
  • 4.3 Assessment of Response for Systemic Disease
  • 4.3.1 Response Based on Morphology for Chemotherapy
  • 4.3.2 Response Based on Morphology for Immunotherapy
  • 4.3.3 Response Based on FDG PET
  • 4.4 Monitoring GIST Molecular Targeted Systemic Therapy
  • 4.4.1 Monitoring GIST with CT/MRI
  • 4.4.2 Monitoring GIST with PET
  • 4.5 Monitoring Liver Disease After SIRT
  • 4.5.1 Monitoring SIRT with CT/MRI
  • 4.5.2 Monitoring SIRT with PET.
  • 4.6 Monitoring Neuroendocrine Tumors
  • 4.7 Monitoring Metastasized Prostate Cancer (I)
  • 4.7.1 Conventional Monitoring of Metastasized Prostate Cancer with CT and Bone Scans
  • 4.7.2 Monitoring Metastasized Prostate Cancer with MRI and PET/CT
  • References
  • 5: Disease of the Gallbladder and Biliary Tree
  • 5.1 Biliary Tract
  • 5.1.1 Congenital Biliary Anomalies
  • 5.1.1.1 Choledochal Cyst
  • 5.1.2 Choledocholithiasis
  • 5.1.3 Inflammatory Disorders (Cholangitis)
  • 5.1.3.1 Suppurative Cholangitis
  • 5.1.3.2 Recurrent Pyogenic Cholangitis
  • 5.1.3.3 Primary Sclerosing Cholangitis
  • 5.1.3.4 IgG4-Related Cholangitis
  • 5.1.4 Neoplasms
  • 5.1.4.1 Benign Tumors of the Bile Ducts
  • Biliary Hamartoma
  • Biliary Cystadenoma (Biliary Mucinous Cystic Neoplasms)
  • Intraductal Papillary Neoplasm of the Bile Duct (IPNB)
  • 5.1.4.2 Malignant Tumors of the Bile Ducts
  • 5.2 Gallbladder
  • 5.2.1 Normal Anatomy
  • 5.2.2 Congenital Variants and Anomalies
  • 5.2.2.1 Agenesis of the Gallbladder
  • 5.2.2.2 Duplication of the Gallbladder
  • 5.2.2.3 Phrygian Cap of the Gallbladder
  • 5.2.2.4 Multiseptate Gallbladder
  • 5.2.2.5 Diverticula of the Gallbladder
  • 5.2.2.6 Ectopic Gallbladder
  • 5.2.3 Pathologic Conditions
  • 5.2.3.1 Gallstones
  • 5.2.3.2 Acute Cholecystitis
  • 5.2.3.3 Acalculous Cholecystitis
  • 5.2.3.4 Chronic Cholecystitis
  • 5.2.3.5 Hyperplastic Cholecystosis
  • 5.2.3.6 Gallbladder Neoplasms
  • 5.3 Concluding Remarks
  • References
  • 6: Pathways for the Spread of Disease in the Abdomen and Pelvis
  • 6.1 Introduction
  • 6.2 Peritoneal Ligaments as Conduits for the Spread of Disease
  • 6.2.1 Gastrohepatic and Hepatoduodenal Ligaments
  • 6.2.2 Gastrosplenic and Splenorenal Ligaments
  • 6.2.3 Gastrocolic Ligament and Transverse Mesocolon
  • 6.3 Peritoneal Spaces as Pathways for the Spread of Disease.
  • 6.3.1 Left Peritoneal Space
  • 6.3.2 Right Peritoneal Space
  • 6.4 Concluding Remarks
  • References
  • 7: Urogenital Pathologies in Children Revisited
  • 7.1 Part I
  • 7.1.1 Urinary Tract by Ultrasound: The BUK Approach
  • 7.1.1.1 Introduction
  • 7.1.1.2 Bladder
  • 7.1.1.3 Ureters
  • 7.1.1.4 Kidneys
  • 7.1.1.5 Summary
  • 7.2 Part II
  • 7.2.1 Female Genital Tract
  • 7.2.1.1 Normal Development
  • 7.2.1.2 Uterus
  • 7.2.1.3 Congenital Abnormalities
  • 7.2.1.4 Ovaries
  • 7.2.1.5 Ovarian Cysts and Other Lesions
  • 7.2.1.6 Ovarian Torsion
  • 7.2.1.7 Ovarian Neoplasm
  • 7.3 Part III
  • 7.3.1 Male Genital Tract
  • 7.3.1.1 Normal Development
  • 7.3.1.2 Congenital Abnormalities
  • 7.3.1.3 Testicular Torsion
  • 7.3.1.4 Inguinal Hernia
  • References
  • 8: Adnexal Diseases
  • 8.1 Introduction
  • 8.2 Imaging Modalities to Assess an Adnexal Mass
  • 8.2.1 Ultrasound (US)
  • 8.2.2 Magnetic Resonance Imaging (MRI)
  • 8.2.3 Computed Tomography (CT)
  • 8.2.4 Positron Emission Tomography/Computed Tomography (PET/CT)
  • 8.3 Adnexal Masses on MRI
  • 8.3.1 Benign Cystic Ovarian Masses
  • 8.3.1.1 Ovarian Cysts
  • 8.3.1.2 Endometriomas
  • 8.3.1.3 Benign Teratomas (Mature Cystic Teratomas or Dermoid Cysts)
  • 8.3.1.4 Cystadenomas
  • 8.3.2 Benign Solid Ovarian Tumors
  • 8.3.3 Borderline and Malignant Ovarian Tumors
  • 8.4 Risk Stratification of Adnexal Masses Using the AdnexMR Score
  • References
  • 9: Adrenal Imaging
  • 9.1 Introduction
  • 9.1.1 Detection of Biochemically Active Adrenal Tumor
  • 9.1.2 Staging Patients with Known Underlying Extra-Adrenal Malignancy
  • 9.1.3 Evaluation of an Incidentally Discovered Adrenal Mass
  • 9.2 Concluding Remarks
  • References
  • 10: Diseases of the Upper GI Tract
  • 10.1 Nonneoplastic Conditions
  • 10.1.1 Gastroesophageal Reflux Disease
  • 10.1.2 Barrett's Esophagus.
  • 10.1.3 Infectious Esophagitis
  • 10.1.4 Eosinophilic Esophagitis
  • 10.1.5 Drug-Induced Esophagitis
  • 10.1.6 Erosive Gastritis
  • 10.1.7 Helicobacter Pylori Gastritis
  • 10.1.8 Gastric Ulcers
  • 10.2 Neoplastic Conditions
  • 10.2.1 Esophageal Cancer
  • 10.2.2 Gastric Cancer
  • 10.2.3 Gastric Lymphoma
  • 10.2.4 Gastrointestinal Stromal Tumor (GIST)
  • 10.2.5 Carcinoid Tumors
  • References
  • 11: Magnetic Resonance Imaging of the Prostate in the PI-RADS Era
  • 11.1 Introduction
  • 11.2 PI-RADS
  • 11.2.1 Clinical Considerations
  • 11.2.2 Technical Considerations
  • 11.2.3 Assessment of Prostatic Lesions
  • 11.2.4 Structured Reporting
  • 11.3 Concluding Remarks
  • Suggested Reading
  • 12: Small Bowel Disease
  • 12.1 Techniques (US, CTE, MRE)
  • 12.2 Normal Anatomy
  • 12.3 Pathology
  • 12.3.1 Emergency
  • 12.3.2 Inflammatory
  • 12.3.2.1 Crohn's Disease (CD)
  • 12.3.2.2 NSAID Enteropathy
  • 12.3.2.3 Celiac Disease
  • 12.3.3 Small Bowel Tumors
  • 12.4 Concluding Remarks
  • References
  • 13: Emergency Radiology of the Abdomen and Pelvis: Imaging of the Non-­traumatic and Traumatic Acute Abdomen
  • 13.1 Imaging Techniques
  • 13.1.1 General Considerations
  • 13.1.2 CT
  • 13.1.3 Ultrasound
  • 13.1.4 Magnetic Resonance Imaging
  • 13.2 Acute Pain in an Abdominal Quadrant
  • 13.2.1 Right Upper Quadrant
  • 13.2.2 Left Upper Quadrant
  • 13.2.3 Right Lower Quadrant
  • 13.2.4 Left Lower Quadrant
  • 13.3 Gynecologic Disorders
  • 13.4 Acute Abdomen with Diffuse Pain
  • 13.4.1 Bowel Obstruction
  • 13.4.2 Bowel Ischemia
  • 13.4.3 Gastrointestinal Perforation
  • 13.4.4 Acute Abdomen with Flank or Epigastric Pain
  • 13.4.5 Urinary Colic
  • 13.4.6 Acute Pancreatitis
  • 13.5 Imaging of Abdominal and Pelvic Trauma
  • 13.5.1 Blunt Abdominal Trauma
  • 13.5.2 Imaging Techniques
  • 13.5.3 Pneumoperitoneum.
  • 13.5.4 Peritoneal Fluid.

Similar Items